Life Science Today

Life Science Today 022 – Interview with COVID19 Survivor

November 30, 2020 Noah Goodson, PhD Season 1 Episode 22
Life Science Today 022 – Interview with COVID19 Survivor
Life Science Today
More Info
Life Science Today
Life Science Today 022 – Interview with COVID19 Survivor
Nov 30, 2020 Season 1 Episode 22
Noah Goodson, PhD

Originally Published as The Niche Podcast

This week, we take a thanksgiving break from the news cycle to bring you a special interview with a COVID survivor and healthcare worker, Trenton Barrick. He shares an inside perspective on the healthcare industry as well as his personal experience being hospitalized with COVID19.

Sponsors
https://www.thescopemethod.com

Trenton's Website
https://www.nmtworks.com/

Aphasia Choir
https://singaphasia.com/

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.



Show Notes

Originally Published as The Niche Podcast

This week, we take a thanksgiving break from the news cycle to bring you a special interview with a COVID survivor and healthcare worker, Trenton Barrick. He shares an inside perspective on the healthcare industry as well as his personal experience being hospitalized with COVID19.

Sponsors
https://www.thescopemethod.com

Trenton's Website
https://www.nmtworks.com/

Aphasia Choir
https://singaphasia.com/

Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.